Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

J. A. McKay, L. J. Murray, Stephanie Curran, V. G. Ross, Caroline Clark, Graeme Ian Murray, J. Cassidy, H. L. McLeod

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine the relevance of EGFR in colorectal cancer, we determined the expression of EGFR protein in 249 colorectal adenocarcinomas and 42 lymph node metastases using immunohistochemistry. Moreover, we investigated a (CA)(n) dinucleotide repeat polymorphism of the EGFR gene in a subset of 114 tumours. High levels of EGFR protein were observed in 123/249 (49.4%) samples. EGFR expression in colorectal carcinomas correlated with differentiation grade (P = 0.014). However, there were no associations with Dukes' stage, site, patient age or gender. EGFR protein expression did not influence survival in this colorectal cancer patient cohort (P greater than or equal to 0.05). Expression was not identical in paired colorectal tumours and lymph node metastases, with only 17/42 (40.5%) samples showing equivalent EGFR levels (P > 0.05). The distribution of the (CA)(n) dinucleotide repeat alleles in colorectal adenocarcinomas was not associated with EGFR protein expression (P > 0.05). These results indicate that while EGFR overexpression is a common event in colorectal carcinogenesis, it does not influence patient prognosis. (C) 2002 Elsevier Science Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)2258-2264
Number of pages6
JournalEuropean Journal of Cancer
Volume38
Issue number17
DOIs
Publication statusPublished - Nov 2002

Keywords

  • colorectal cancer
  • epidermal growth factor receptor
  • prognosis
  • polymorphism
  • immunohistochemistry
  • lymph node metastases
  • colon carcinoma cells
  • dinonucleotide repeat
  • signaling network
  • nuclear antigen
  • cyclin D1
  • cancer
  • expression
  • overexpression
  • intron 1

Cite this

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. / McKay, J. A.; Murray, L. J.; Curran, Stephanie; Ross, V. G.; Clark, Caroline; Murray, Graeme Ian; Cassidy, J.; McLeod, H. L.

In: European Journal of Cancer, Vol. 38, No. 17, 11.2002, p. 2258-2264.

Research output: Contribution to journalArticle

McKay, J. A. ; Murray, L. J. ; Curran, Stephanie ; Ross, V. G. ; Clark, Caroline ; Murray, Graeme Ian ; Cassidy, J. ; McLeod, H. L. / Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. In: European Journal of Cancer. 2002 ; Vol. 38, No. 17. pp. 2258-2264.
@article{d86b0bde189945ed9116d7e087f57c8e,
title = "Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases",
abstract = "Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine the relevance of EGFR in colorectal cancer, we determined the expression of EGFR protein in 249 colorectal adenocarcinomas and 42 lymph node metastases using immunohistochemistry. Moreover, we investigated a (CA)(n) dinucleotide repeat polymorphism of the EGFR gene in a subset of 114 tumours. High levels of EGFR protein were observed in 123/249 (49.4{\%}) samples. EGFR expression in colorectal carcinomas correlated with differentiation grade (P = 0.014). However, there were no associations with Dukes' stage, site, patient age or gender. EGFR protein expression did not influence survival in this colorectal cancer patient cohort (P greater than or equal to 0.05). Expression was not identical in paired colorectal tumours and lymph node metastases, with only 17/42 (40.5{\%}) samples showing equivalent EGFR levels (P > 0.05). The distribution of the (CA)(n) dinucleotide repeat alleles in colorectal adenocarcinomas was not associated with EGFR protein expression (P > 0.05). These results indicate that while EGFR overexpression is a common event in colorectal carcinogenesis, it does not influence patient prognosis. (C) 2002 Elsevier Science Ltd. All rights reserved.",
keywords = "colorectal cancer, epidermal growth factor receptor, prognosis, polymorphism, immunohistochemistry, lymph node metastases, colon carcinoma cells, dinonucleotide repeat, signaling network, nuclear antigen, cyclin D1, cancer, expression, overexpression, intron 1",
author = "McKay, {J. A.} and Murray, {L. J.} and Stephanie Curran and Ross, {V. G.} and Caroline Clark and Murray, {Graeme Ian} and J. Cassidy and McLeod, {H. L.}",
year = "2002",
month = "11",
doi = "10.1016/S0959-8049(02)00234-4",
language = "English",
volume = "38",
pages = "2258--2264",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "17",

}

TY - JOUR

T1 - Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

AU - McKay, J. A.

AU - Murray, L. J.

AU - Curran, Stephanie

AU - Ross, V. G.

AU - Clark, Caroline

AU - Murray, Graeme Ian

AU - Cassidy, J.

AU - McLeod, H. L.

PY - 2002/11

Y1 - 2002/11

N2 - Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine the relevance of EGFR in colorectal cancer, we determined the expression of EGFR protein in 249 colorectal adenocarcinomas and 42 lymph node metastases using immunohistochemistry. Moreover, we investigated a (CA)(n) dinucleotide repeat polymorphism of the EGFR gene in a subset of 114 tumours. High levels of EGFR protein were observed in 123/249 (49.4%) samples. EGFR expression in colorectal carcinomas correlated with differentiation grade (P = 0.014). However, there were no associations with Dukes' stage, site, patient age or gender. EGFR protein expression did not influence survival in this colorectal cancer patient cohort (P greater than or equal to 0.05). Expression was not identical in paired colorectal tumours and lymph node metastases, with only 17/42 (40.5%) samples showing equivalent EGFR levels (P > 0.05). The distribution of the (CA)(n) dinucleotide repeat alleles in colorectal adenocarcinomas was not associated with EGFR protein expression (P > 0.05). These results indicate that while EGFR overexpression is a common event in colorectal carcinogenesis, it does not influence patient prognosis. (C) 2002 Elsevier Science Ltd. All rights reserved.

AB - Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine the relevance of EGFR in colorectal cancer, we determined the expression of EGFR protein in 249 colorectal adenocarcinomas and 42 lymph node metastases using immunohistochemistry. Moreover, we investigated a (CA)(n) dinucleotide repeat polymorphism of the EGFR gene in a subset of 114 tumours. High levels of EGFR protein were observed in 123/249 (49.4%) samples. EGFR expression in colorectal carcinomas correlated with differentiation grade (P = 0.014). However, there were no associations with Dukes' stage, site, patient age or gender. EGFR protein expression did not influence survival in this colorectal cancer patient cohort (P greater than or equal to 0.05). Expression was not identical in paired colorectal tumours and lymph node metastases, with only 17/42 (40.5%) samples showing equivalent EGFR levels (P > 0.05). The distribution of the (CA)(n) dinucleotide repeat alleles in colorectal adenocarcinomas was not associated with EGFR protein expression (P > 0.05). These results indicate that while EGFR overexpression is a common event in colorectal carcinogenesis, it does not influence patient prognosis. (C) 2002 Elsevier Science Ltd. All rights reserved.

KW - colorectal cancer

KW - epidermal growth factor receptor

KW - prognosis

KW - polymorphism

KW - immunohistochemistry

KW - lymph node metastases

KW - colon carcinoma cells

KW - dinonucleotide repeat

KW - signaling network

KW - nuclear antigen

KW - cyclin D1

KW - cancer

KW - expression

KW - overexpression

KW - intron 1

U2 - 10.1016/S0959-8049(02)00234-4

DO - 10.1016/S0959-8049(02)00234-4

M3 - Article

VL - 38

SP - 2258

EP - 2264

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 17

ER -